CN108850923A - A kind of preparation method of fruit functional red yeast rice - Google Patents
A kind of preparation method of fruit functional red yeast rice Download PDFInfo
- Publication number
- CN108850923A CN108850923A CN201810724359.1A CN201810724359A CN108850923A CN 108850923 A CN108850923 A CN 108850923A CN 201810724359 A CN201810724359 A CN 201810724359A CN 108850923 A CN108850923 A CN 108850923A
- Authority
- CN
- China
- Prior art keywords
- fruit
- red yeast
- yeast rice
- functional red
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940026314 red yeast rice Drugs 0.000 title claims abstract description 102
- 235000013399 edible fruits Nutrition 0.000 title claims abstract description 73
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 238000000855 fermentation Methods 0.000 claims abstract description 48
- 230000004151 fermentation Effects 0.000 claims abstract description 48
- 244000068988 Glycine max Species 0.000 claims abstract description 40
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 40
- 239000007788 liquid Substances 0.000 claims abstract description 38
- 241000209140 Triticum Species 0.000 claims abstract description 24
- 235000021307 Triticum Nutrition 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 235000021022 fresh fruits Nutrition 0.000 claims abstract description 18
- 230000000813 microbial effect Effects 0.000 claims abstract description 7
- 238000004321 preservation Methods 0.000 claims abstract description 4
- 238000002703 mutagenesis Methods 0.000 claims abstract description 3
- 231100000350 mutagenesis Toxicity 0.000 claims abstract description 3
- 210000002966 serum Anatomy 0.000 claims description 22
- 230000001954 sterilising effect Effects 0.000 claims description 20
- 229920001202 Inulin Polymers 0.000 claims description 17
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 17
- 229940029339 inulin Drugs 0.000 claims description 17
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
- 239000004615 ingredient Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 244000113306 Monascus purpureus Species 0.000 claims description 11
- 238000004140 cleaning Methods 0.000 claims description 11
- 235000002322 Monascus purpureus Nutrition 0.000 claims description 10
- 229930091371 Fructose Natural products 0.000 claims description 9
- 239000005715 Fructose Substances 0.000 claims description 9
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 9
- 239000004310 lactic acid Substances 0.000 claims description 8
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 238000005360 mashing Methods 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 5
- 239000002054 inoculum Substances 0.000 claims description 5
- 229940057059 monascus purpureus Drugs 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 230000036541 health Effects 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 8
- 239000000126 substance Substances 0.000 abstract description 8
- 241000228347 Monascus <ascomycete fungus> Species 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 4
- 239000000758 substrate Substances 0.000 abstract description 4
- 230000035790 physiological processes and functions Effects 0.000 abstract description 3
- 230000035622 drinking Effects 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract description 2
- 230000010354 integration Effects 0.000 abstract description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 37
- 230000000694 effects Effects 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 230000006870 function Effects 0.000 description 21
- 150000002632 lipids Chemical class 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 244000157072 Hylocereus undatus Species 0.000 description 15
- 235000018481 Hylocereus undatus Nutrition 0.000 description 15
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 15
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 15
- 229960004844 lovastatin Drugs 0.000 description 15
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 15
- 235000012000 cholesterol Nutrition 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 108010028554 LDL Cholesterol Proteins 0.000 description 12
- 239000000047 product Substances 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 238000005259 measurement Methods 0.000 description 8
- 208000024172 Cardiovascular disease Diseases 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 108010023302 HDL Cholesterol Proteins 0.000 description 5
- 208000026106 cerebrovascular disease Diseases 0.000 description 5
- 230000002526 effect on cardiovascular system Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 150000002596 lactones Chemical class 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000009102 absorption Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108010010234 HDL Lipoproteins Proteins 0.000 description 3
- 102000015779 HDL Lipoproteins Human genes 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- -1 flavanol compound Chemical class 0.000 description 3
- 229930003935 flavonoid Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 239000008802 xuezhikang Substances 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 150000004666 short chain fatty acids Chemical class 0.000 description 2
- 235000021391 short chain fatty acids Nutrition 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 238000008620 Cholesterol Assay Methods 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 241000209094 Oryza Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical group O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Chemical class 0.000 description 1
- 229930002877 anthocyanin Chemical class 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- CQIUKKVOEOPUDV-IYSWYEEDSA-N antimycin Chemical compound OC1=C(C(O)=O)C(=O)C(C)=C2[C@H](C)[C@@H](C)OC=C21 CQIUKKVOEOPUDV-IYSWYEEDSA-N 0.000 description 1
- 210000000026 apposition eye Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- CQIUKKVOEOPUDV-UHFFFAOYSA-N citrinine Natural products OC1=C(C(O)=O)C(=O)C(C)=C2C(C)C(C)OC=C21 CQIUKKVOEOPUDV-UHFFFAOYSA-N 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 210000001842 enterocyte Anatomy 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Chemical class O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical group O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical group 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/41—Retaining or modifying natural colour by use of additives, e.g. optical brighteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/20—Malt products
- A23L7/25—Fermentation of cereal malt or of cereal by malting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Abstract
The invention belongs to technical field of microbial fermentation, and in particular to a kind of preparation method of fruit functional red yeast rice.The preparation method of fruit functional red yeast rice is made using practicing No. ten Flight Mutagenesis functional mutant red yeast rice strain K10406 as raw material, and microbial preservation number is:CGMCC NO.13773.The preparation method of the fruit functional red yeast rice, including(1)Fresh fruit is taken, it is spare;(2)Functional red yeast rice strain K10406 is inoculated in using fresh fruit as in the material of primary raw material, fermentation obtains fruit functional red yeast rice.The present invention uses fresh fruit for main fermentation substrate, and using soybean, synanthrin and wheat germ powder as auxiliary material, in conjunction with the abundant nutrition substance contained in the fermentation raw materials such as the fruit distinctive physiological function of functional red yeast rice fermentation liquid functional Monascus and fresh fruit, so that fruit functional red yeast rice of the invention is had higher integration of drinking and medicinal herbs value, can be widely applied to food, health care and medicine and other fields.
Description
Technical field
The invention belongs to technical field of microbial fermentation, and in particular to a kind of preparation method of fruit functional red yeast rice.
Background technique
104195051 A of CN discloses the preparation method and product of a kind of function dragon fruit red yeast rice, and preparation method is difference
Preparing dragon fruit culture medium, Monascus anka Nakazawa et sato filament and preparation function dragon fruit red yeast rice, the Monascus anka Nakazawa et sato filament is with red yeast rice red yeast rice
Bacterium (Monascus purpureus yangTY622) be strain, the culture through slant medium, liquid Shake flask medium, together
Shi Caiyong ultraviolet light-dithyl sulfate carries out complex mutation to strain, fermentation medium is accessed later, through liquid state fermentation culture
And it is made;The function dragon fruit red yeast rice is that Monascus anka Nakazawa et sato filament, probiotics or lactic acid bacteria are accessed dragon fruit pulp culture medium
It is middle to be obtained through liquid state fermentation.Function dragon fruit red yeast rice provided by the invention, has the plurality of health care functions of dragon fruit and red yeast rice concurrently,
Not only have the effects that reducing blood lipid, the blood pressure lowering, hypoglycemic, toxin-expelling and face nourishing, anti-old lesion, solution also with dragon fruit of red yeast rice
Removing heavy metals poisoning and other effects, is able to satisfy more Man's Demands.
The above-mentioned main scheme of document is as follows:
(1) dragon fruit culture medium:
Dragon fruit is cleaned, peeling, is by weight dragon fruit pulp 1:Sterile water 1-10 is placed in beater to be made through mashing
At
Then pulp adds rice flour 1-3g, KH2PO40.1-0.9g, NaNO30.6-0.8g, MgSO40.5- in every liter of pulp
0.6g,
Potato 0.9-1.2g.
(2) Monascus anka Nakazawa et sato filament:
Selection red yeast rice Monascus Monascus purpureus yang TY622 bacterial strain is strain, and microbial preservation number is
CGMCC4110 ;Culture at 30-40 DEG C through slant medium, liquid Shake flask medium, while using ultraviolet light-sulfuric acid
Diethylester carries out complex mutation to strain, to reduce citrinin content, accesses fermentation medium later, carries out liquid state fermentation culture
Generate Monascus anka Nakazawa et sato filament;
(3) preparation of function dragon fruit red yeast rice:
On the basis of the weight of dragon fruit culture medium described in step (1), by weight percentage described in addition step (2)
Monascus anka Nakazawa et sato filament 10-60%, sterile water 20-30% in 120 DEG C of sterilizing 25min, then are inoculated with 5-10%'s by weight percentage
Probiotics or lactic acid bacteria, 25-35 DEG C fermented and cultured 6-8 days, can produce to obtain function dragon fruit red yeast rice.
The preparation method and product of above functions dragon fruit red yeast rice, to Monascus anka Nakazawa et sato filament through inclined-plane culture at 30-40 DEG C
The culture of base, liquid Shake flask medium, while complex mutation is carried out to strain using ultraviolet light-dithyl sulfate, to reduce tangerine
Mycin content, defect are to need to carry out complex mutation to strain using ultraviolet-dithyl sulfate, do not have reproducibility, no
Meet the requirement of practicability.
Summary of the invention
In order to solve the above technical problems, the present invention provides one kind using fruit as primary raw material, supplemented by soybean etc.
The preparation method of the functional red yeast rice of material prepares resulting functional red yeast rice effect in terms of preventing cardiovascular and cerebrovascular disease by this method
Significantly, food, the medicine field conducive to human health be can be widely applied to;It gets a promotion simultaneously in terms of its sense organ and effect.
The preparation method of fruit functional red yeast rice of the invention, the fruit functional red yeast rice is to practice No. ten Flight Mutagenesis mutation function
Energy red yeast rice strain K10406 is made for raw material, and microbial preservation number is:CGMCC NO.13773.
The preparation method of fruit functional red yeast rice includes the steps that following:
(1)Fresh fruit is taken, it is spare;
(2)Functional red yeast rice strain K10406 is inoculated in using fresh fruit as in the material of primary raw material, fermentation obtains fruit function
Red yeast rice.
This method is specially:Fresh fruit is cleaned, removes fruit stone, will be impregnated together with soybean after fruit slice, is beaten, matches
Material, sterilizing are inoculated with functional red yeast rice strain, and fermented and cultured obtains fruit functional red yeast rice.
Above-mentioned fruit is apple.
The preparation method of fruit functional red yeast rice includes the steps that following:
S1:Pretreatment:Deseeding after fruit cleaning, slice, soybean warm water impregnate 2-12h, mashing;
S2:Ingredient:Each raw material is taken by following parts by weight:Fruit 50-90, soybean 1- after taking cleaning and deseeding in S1 or being enucleated
10, fructose 0.01-0.1, inulin 1-10, wheat germ powder 0.01-0.15 adjust pH 3-4;
S3:Material in sterilizing S2;
S4:Liquid functional red yeast rice strain K10406 is accessed, fermented and cultured obtains fruit functional red yeast rice fermentation liquid, fermentation liquid is dried,
Color value is detected, crushes, obtains fruit functional red yeast rice.
The preparation method of above-mentioned fruit functional red yeast rice, includes the steps that following:
S1:Pretreatment:Deseeding after apple cleaning, slice, soybean warm water impregnate 2-12h, mashing;
S2:Ingredient:Each raw material is taken by following parts by weight:Take the apple 50-90 after cleaning simultaneously deseeding in S1, soybean 1-10, fruit
Sugared 0.01-0.1, inulin 1-10, wheat germ powder 0.01-0.15 adjust pH 3-4;
S3:Material in sterilizing S2;
S4:Liquid functional red yeast rice strain K10406 is accessed, fermented and cultured obtains fruit functional red yeast rice fermentation liquid, fermentation liquid is dried,
Color value is detected, crushes, obtains fruit functional red yeast rice.
The preparation method of fruit functional red yeast rice specifically includes following steps:
S1:Apple and soybean pretreatment:Fresh apple is cleaned, deseeding is sliced, and warm water soaking soybean 2-12h utilizes beater
Obtain the mixed serum of the two;
S2:Ingredient:Each raw material is taken by following parts by weight:Apple 50-90 obtained in S1, soybean 1-10, fructose 0.01-0.1,
Inulin 1-10, wheat germ powder 0.01-0.15 utilize lactic acid tune pH 3-4;
S3:Material in sterilizing S2;
S4:Liquid functional red yeast rice strain is accessed, is planted age 48 hours, inoculum concentration 5-20% fermented and cultured 5-15 days, obtains fruit function
Monas cuspurpureus Went fermentation liquid dries fermentation liquid, carries out color value detection, pulverizes to 600-1000 mesh, sterilizing obtains fruit functional red yeast rice
Powder.
In S3, sterilization steps are sterilized 20 minutes at 1kg/cm2,121 DEG C.
The beneficial effects of the present invention are:
(1) present invention uses fresh fruit for main fermentation substrate, and using soybean, synanthrin and wheat germ powder as auxiliary material, utilizes
Lactic acid adjust fermentation liquid pH carry out apple pulp color protection, by the fruit distinctive physiological function of functional red yeast rice fermentation liquid functional Monascus with
The abundant nutrition substance contained in the fermentation raw materials such as fresh fruit is combined, such as phenols, anthocyanidin, isoflavones, solubility
Mineral matter element necessary to dietary fiber and human body, vitamin etc. have fruit functional red yeast rice of the invention higher
Integration of drinking and medicinal herbs value, can be widely applied to food, health care and medicine and other fields;
(2) present invention uses fruit for primary raw material, and fructose content is higher in fresh fruit, while the addition of inulin can extend carbon
The supply time in source, but blood glucose is not improved, mitigate diabetic to the dependence of insulin, in addition to this, in fresh fruit
Polyphenols rich in, substance of this kind can be used as the inhibitor of hypertension and hyperlipidemia, in soybean and wheat germ powder
The effect of unsaturated fatty acid abundant also has prevention of arterial atherosis, reduces cholesterol, such lowering blood pressure and blood fat
The physiological activity factor in effect combination red yeast rice, such as the norcholesterol and other effects of the Mo Nakelin K factor, gather around fruit functional red yeast rice
There is natural prevention cardiovascular and cerebrovascular disease;
(3) present invention carries out post-production to the solids after the drying of fruit functional red yeast rice fermentation liquid using superfine communication technique,
It is set to be easier to store and apply.For fruit functional red yeast rice in sensory aspect, strong fragrance and the natural red yeast rice for possessing fresh fruit are special
Some colors combine the physiological active functions of plurality of raw materials and red yeast rice metabolin in terms of effect, and therefore, fruit function is red
Bent nutrition and health care with higher and application value.
Detailed description of the invention:
Fig. 1 show apple functional red yeast rice chromatogram of the invention in embodiment 4;
Fig. 2 show the apple functional red yeast rice fermentation time and Lovastatin content curve graph one of the method for the present invention preparation;
Fig. 3 show the apple functional red yeast rice fermentation time and Lovastatin content curve graph two of the method for the present invention preparation;
Fig. 4 show the apple functional red yeast rice fermentation time and Lovastatin content curve graph three of the method for the present invention preparation.
Specific embodiment:
For a better understanding of the present invention, below with specific example come the technical solution that the present invention will be described in detail, but it is of the invention
It is not limited thereto.
Embodiment 1
By taking the preparation method of apple functional red yeast rice as an example, its step are as follows:
S1:Apple and soybean pretreatment:Fresh apple is cleaned, deseeding is sliced, and warm water soaking soybean 2-12h utilizes beater
Obtain the mixed serum of the two;
S2:Ingredient:Each raw material is taken by following parts by weight:Apple 80 obtained in S1, soybean 8, fructose 0.06, inulin 7 are small
Wheat germ powder 0.12 utilizes lactic acid tune pH 3-4;
S3:Material in sterilizing S2;Sterilising conditions are:1kg/cm2, sterilize 20 minutes at 121 DEG C;
S4:Liquid functional red yeast rice strain is accessed, is planted age 48 hours, inoculum concentration 12% fermented and cultured 10 days, obtains fruit functional red yeast rice
Fermentation liquid dries fermentation liquid, carries out color value detection, pulverizes to 800 mesh, sterilizing obtains fruit functional red koji powder.
The inventive concept of the present embodiment is:
Fresh apple main nutrient composition has polyphenol(Phenolic acid and flavonoid class ingredient), the chemical substances such as triterpene and phytosterol,
Protein, vitamin, sugar and microelement also rich in herein.Apple polyphenol is a kind of very strong antioxidant, tool
Play the role of preferably removing free radical, wherein main component is flavonoid class compound, it is highest one kind of content in apple
Ingredient mainly includes flavonoids, flavonols, flavanol compound, anthocyanin class, chalcone and its derivative etc..Research shows that
The nutritional ingredient of apple has good anti-allergenicity, anti-caries effect, inhibits the physiological functions such as blood pressure rising, great exploitation
Potentiality.Why the present invention uses fresh Yantai apple for main fermentation substrate, is primarily due to apple rich in polysaccharide, mainly
Ingredient is galacturonic acid, lactose, arabinose, glucuronic acid etc., additionally containing a large amount of monosaccharide and disaccharide etc..It is abundant
Glucide sufficient carbon source material can be provided for the growth and metabolism of monascus, promote effective product of physiological activator
It is tired.Microelement in fresh apple in addition to can be absorbed by the body can also be played in monascus growth course other than growth because
The effect of son, such microelement includes VA、VC、VEWith multivitamins constituents such as beta carotene and needed by human micro
Element, such as calcium, iron, potassium, manganese, zinc, magnesium, copper, sulphur.Once there is the condensed tannin class in Japanese scholars research discovery apple polyphenol
ACE(Angiotensin converting enzyme)Inhibitory activity is higher than tea polyphenols, can be used as hypertension, hyperlipemia and cardiovascular and cerebrovascular disease
Inhibit medicament.Therefore, fruit functional red yeast rice made of the active material accumulated during fresh apple combination red koji fermentation is dropping
Blood pressure, reducing blood lipid etc. have biggish functions of prevention and health care.
This product is using soybean as red koji fermentation main nitrogen, in terms of the healthcare function for being conceived to soybean itself, due to big
Contain a large amount of bioactive substance in beans, positive prevention effect is played to cardiovascular disease and atherosclerosis.Example
Such as, it is that can do outside nitrogen source that soybean, which removes soybean protein rich in, also contains a certain amount of soyabean oligosaccharides, and main component is
Stachyose, gossypose, sucrose, while also including a small amount of glucose, fructose and galactolipin, soyabean oligosaccharides can promote in enteron aisle
Beneficial bacterium Bifidobacterium proliferation, improve enteric bacteria group structure, can simultaneously because the inducing immunity of Bifidobacterium
It enhances human immunity.Once test proves that lactobacillus acidophilus can be by influencing penta 2 list acyl coenzyme A of beta-hydroxy-Beta-methyl reduction
The activity of enzyme controls the synthesis of cholesterol, plays the role of reducing blood pressure and blood fat.Therefore, soybean is widely used in food guarantor
Strong field.For soybean for microbial fermentation, soya-bean polypeptides have the accumulation of microorganism growth and development and secondary metabolite
There is positive facilitation.In addition to this, containing there are many amino acid substances to play important growth to red yeast rice growth in soybean
The effect of the factor.
The auxiliary material that the present invention uses mainly includes inulin and wheat germ powder, and inulin is naturally occurring solvable in nature
Property one of dietary fiber, the obvious effect in terms of control blood glucose and cholesterol, inulin do not need pancreas islet during body metabolism
Element can reduce diabetes patient to the dependence of insulin, control blood glucose.Mechanism of the synanthrin in terms of reducing blood lipid includes:Adsorb intestines
Intracavitary bile acid reduces the reabsorption of bile acid, and cholesterol is blocked to recycle in enteric cavity;Reduce the absorptivity of cholesterol in diet;
By big enteral beneficial bacterium fermentative degradation, generated short chain fatty acids and lactate have inhibition to the biosynthesis of hepatic cholesterol
Effect.In addition to this, inulin can improve the absorption of the minerals such as calcium, iron, potassium, manganese, zinc, magnesium, this is because inulin is in fermentation
It being degraded, the short chain fatty acids generated reduce the pH value inside enteron aisle by 1~2 unit, metal ion solubility is increased,
Therefore, synanthrin can promote the absorption of metal ion in fresh fruit, and more metal ions is made to enter enterocyte for absorption of human body.
Wheat is known as " honors of five cereals ", wherein dietary fiber rich in, vitamin, carotenoid (turn in human body
Turn to vitamin A), unsaturated fatty acid, high-quality complete protein, the sweet skin of paddy skin and wheat flavones, but also must containing human body
The several mineral materials needed.Core and vital center of the wheat embryo as wheat berry are worth with high comprehensive nutrient, by
Countries in the world nutritionist is described as " the natural nutrition treasure-house of the mankind ".The glutathione contained in wheat germ powder is a kind of sulfur-bearing
Certain health care effect is consequently formed in polyphenoils.The common feature of wheat germ powder and inulin is all containing abundant
Dietary fiber, important adjustment effect is played to human body intestinal canal flora, but the advantage of wheat germ powder is wheat embryo
In linoleic acid rich in, the unsaturated fatty acid reduce serum cholesterol concentration, prevention and treatment atherosclerosis in terms of make
With significant, while the wheat flavones wherein contained also has certain effect to cardiovascular disease.
Functional Monascus is carried out liquid fermentation using above-mentioned raw materials as fermentation substrate, China early just starts to eat red in ancient times
Song,《Compendium of Materia Medica》In once recorded its smell " sweet, warm, nontoxic " of the characteristic of red yeast rice, function, which cures mainly, " woman's qi and blood pain and to be produced
Extravesated blood is not to the utmost afterwards ".《Yin Shan Zhengyao, Principles of Correct Diet》Middle description red yeast rice " strengthening the spleen and replenishing qi, middle benefit gas ",《A supplement to augmented materia medica》Red yeast rice can " promoting blood circulation disappears title
It eats, build warm stomach, control trough under dysentery ".Functional red yeast rice can provide multiple active enzymes in the metabolic process in modern study,
Such as amylase, carbohydrase, protease, monascus generate function carbohydrate, unsaturated fatty acid, drop under the action of these enzymes
Press the factor(Such as Mo Nakelin K, ergosterol and γ-aminobutyric acid)Equal substances, so that red koji fermentation object be made to have drop blood
The extensive health-care effect such as rouge, blood pressure lowering, hypoglycemic, antifatigue, adjusting gastrointestinal health.
Therefore, the product-in conjunction with made of the composite health-caring functional of fresh fruit, inulin, soybean, wheat germ powder and red yeast rice
Fruit functional red yeast rice, the obvious effect in terms of preventing cardiovascular and cerebrovascular disease can be widely applied to food, the medicine conducive to human health
Product field, especially fruit functional red yeast rice not only possess the unique fragrance of apple and also possess the color that red yeast rice pleases people, can apply
In the field of functional beverage etc., makes it in terms of sense organ and effect while getting a promotion.
Embodiment 2
A kind of preparation method of fruit functional red yeast rice, its step are as follows:
S1:Apple and soybean pretreatment:Deseeding after apple cleaning, slice, soybean warm water impregnate, and the two mixing utilizes beater
Slurries are made;
S2:Ingredient:Each raw material is taken by following parts by weight:Apple 60-80 obtained in S1, soybean 2-8, fructose 0.01-0.2,
Inulin 1-10, wheat germ powder 0.01-0.15 utilize lactic acid tune pH 3-4;
S3:Material in sterilizing S2;
S4:Liquid functional red yeast rice strain is accessed, is planted age 48 hours, inoculum concentration 5-15%, fermented and cultured 15 days, until Lovastatin contains
Until amount is 2.0mg/g, fruit functional red yeast rice fermentation liquid is obtained, fermentation liquid is dried, pulverized to 600 mesh, carry out color value
Detection, color value 500U/g, sterilizing obtain fruit functional red koji powder.
Embodiment 3
A kind of preparation method of fruit functional red yeast rice, its step are as follows:
S1:Apple and soybean pretreatment:Deseeding after apple cleaning, slice, soybean warm water impregnate, and the two mixing utilizes beater
Slurries are made;
S2:Ingredient:Each raw material is taken by following parts by weight:Apple 60-80 obtained in S1, soybean 2-8, fructose 0.01-0.2,
Inulin 1-10, wheat germ powder 0.01-0.15 utilize lactic acid tune pH 3-4;
S3:Material in sterilizing S2;
S4:Liquid functional red yeast rice strain is accessed, is planted age 48 hours, inoculum concentration 10%, fermented and cultured 13 days, until Lovastatin content
Until for 2.0mg/g, fruit functional red yeast rice fermentation liquid is obtained, fermentation liquid is dried, pulverized to 800 mesh, carry out color value inspection
It surveys, color value 350U/g, sterilizing obtains fruit functional red koji powder.
Embodiment 4
Apple functional red yeast rice obtained in Example 1-3 measures the content of Lovastatin therein, and specific detection method is such as
Under:
(1)Sample pretreating:Fruit functional red koji powder 0.1-0.5g sample is accurately weighed in 50ml volumetric flask.75% ethyl alcohol is added
To close to graduation mark, then ultrasound 5-15min, it is cooled to room temperature later, is settled to 50ml with 75% ethyl alcohol.With 2000-4000r/
The rotation speed of min is centrifuged 5-15min.Supernatant is gone to filter through 0.2-0.5 μm of micropore filtering film, filtrate is stand-by.
(2)Liquid-phase chromatographic column reference conditions
Chromatographic column:C18 column
Column temperature:20-25 DEG C of room temperature
UV detector:238nm Detection wavelength
Mobile phase:Methanol:Water:Phosphoric acid=(300-400):(100-120):(0.1-0.2)
Flow velocity:0.5-1.5ml/min
Sample volume:20μl
(3)Standard curve preparation
Compound concentration is 0.1,1,10,30,75,150,300 μ g/ml Lovastatin standard solution.When analysis, balanced with eluent
The Lovastatin titer of various concentration is carried out HPLC analysis after baseline stability by analytical column, is measured peak area, is with peak area
Ordinate, using Lovastatin content as abscissa, linear relationship is good, and r carries out subsequent sample measurement at 0.9995 or more.
(4)Chromatography
The 20 μ l sample introduction of sample extracting solution that will be handled well, compareed with standard solution retention time it is qualitative, with tested component lactones and
The sum of acid Lovastatin peak area and standard Lovastatin(Lactones)The ratio between peak area quantified.Chromatographic results such as explanation
Shown in book attached drawing Fig. 1.
(5)As a result it calculates
X=(H1+H2)×C×50/(H3×m)
In formula:Mo Nakelin K content in X- sample, unit mg/g;
Lactones formula Lovastatin area in H1- sample;
Acid Lovastatin peak area in H2- sample;
C- standard Lovastatin(Lactones)Solution concentration, units/ml;
50- sample constant volume
H3- standard Lovastatin(Lactones)Solution peak area.
As shown in Figure of description Fig. 2, Fig. 3, Fig. 4, the apple functional red yeast rice fermentation time of the method for the present invention preparation and Lip river
Cut down statin content curve graph.
Blood glucose is not improved about functional red yeast rice of the invention, mitigates diabetic to the dependence fresh fruit of insulin
In polyphenols rich in, substance of this kind can be used as the inhibitor of hypertension and hyperlipidemia, soybean and wheat germ powder
In unsaturated fatty acid abundant the effect of also there is prevention of arterial atherosis, reduce cholesterol, such lowering blood pressure and blood fat
The effect of combine the physiological activity factor in red yeast rice, such as the norcholesterol and other effects of the Mo Nakelin K factor makes fruit functional red yeast rice
Have the effect of natural prevention cardiovascular and cerebrovascular disease.
Embodiment 5
The Evaluation of Functional test for having done reducing blood lipid to product prepared by embodiment 1 reduces blood lipid according to the type of dyslipidemia
Function sets up the animal experiment of classification according to the difference of tested material mechanism of action.Experiments have shown that 1 product of embodiment can be effective
Improve the plasma lipid profile and oxidative stress status of blood lipid mouse, it is the most significant with effect when high dose, can make in serum TC and
LDL-C content reduces by 52.5% and 35.4% respectively;Make serum T-AOC and SOD level that 83.2% and 13.4% be respectively increased simultaneously, and
It can reach and normally organize comparable level.Evaluation test method is as follows:
1. principle
Disorders of lipid metabolism animal model can be formed with the forage feed animal containing cholesterol, sucrose, lard, sodium taurocholate, then is given
Animal given the test agent is given, can detect influence of the given the test agent to hyperlipidemia, and can determine that absorption of the given the test agent to lipid, rouge
The influence that the formation of albumen, the degradation of lipid or excretion generate.
2. material and instrument
Conventional feed ingredient:Carbohydrate:59%, protein:21.1%, fiber:4.9%, fat:4.2%, ash content:8%, phosphorus:
1%, calcium:1.8%.
High lipid food ingredient:Carbohydrate 48%, protein 21.1%, fat 4.2%, fiber 4.7%, ash content 8%, phosphorus 1%,
Calcium 1.8%, lard 10%, cholate 0.2%, cholesterol 1%.
Above-mentioned feed is purchased from Beijing animal experimental center.
Triglyceride determination kit(GPO-POD method), cholesterol determination kit(CO-POD method), low-density lipoprotein
Cholesterol determination kit(Direct method), high-density lipoprotein cholesterol assay kit(Direct method), total superoxide dismutase
Enzyme(T-SOD)Testing cassete, total antioxidant capacity(T-AOC)Science and Technology Ltd. is built up in assay kit, Nanjing;Other reagents are equal
It is pure for domestic analysis.
SpectraMax13 continuous wavelength multi-function microplate reader, Molecular Devices company of the U.S.;SIGMA 3K15
Desk centrifuge, Beijing Five continents east development in science and technology Co., Ltd;SIGMA 1-14 desk centrifuge, Beijing Five continents east science and technology
Development Co., Ltd;TBA-40 automatic clinical chemistry analyzer, Japanese Toshiba Medical Systerm Co., Ltd.
3. animal packet and modeling method
First by ICR mouse(Male, 18-22g, Beijing Vital River Experimental Animals Technology Co., Ltd. provide, quality certification number:
SCXK(Capital)2012-0001.)Raising one week, room ventilation condition is good, normal day-night change(8:00am-8:00pm), relatively
Humidity is 55 ± 5%, room temperature:23±2oC.It is fed with chow diet, freely adopts water, feeding.6 groups are randomly divided by weight after 1 week,
I.e. normal group, high lipid food group, Effects of Xuezhikang group, 1 product of embodiment is low(70 mg/kg.d), in(140 mg/kg.d), high dose
Group(210 mg/kg.d).In addition to Normal group is fed with normal diet, remaining each group is fed with high lipid food, and groups of animals is certainly
By adopting water, feeding.Test period is 12 weeks.
4. lipid-loweringing is tested
After zoopery starts, 1 product of embodiment and Effects of Xuezhikang press above-mentioned dosage and carry out stomach-filling, normal group and high lipid food group
Stomach-filling is carried out using distilled water.It continuous 12 weeks, weighs 1 time every three days, satellite recanalization dosage.Administration on the day before off-test
It is fasted at night afterwards, fasting 12-14 h, unlimited drinking-water, next day eye socket takes blood, measures serum total cholesterol(TC), total glycerol
Three esters(TG), low density lipoprotein cholesterol(LDL-C)And high-density lipoprotein cholesterol(HDL-C), total antioxidant capacity(T-
AOC)And superoxide dismutase(SOD)Content.
5. the measurement of lipid-loweringing test index
5.1. the measurement of blood lipid
100 μ L of serum is taken, then with normal saline dilution to 400 μ L.With automatic clinical chemistry analyzer measure serum TC, TG,
The content of LDL-C and HDL-C.The measurement of TC uses CHOD-PAP method;The measurement of TG uses GPO-PAP method;LDL-C and HDL-C
Measurement be all made of removing method;The above index is using Japanese Toshiba Medical Systerm Co., Ltd TBA-40 automatic clinical chemistry analyzer
Measurement, concrete operations are illustrated to carry out by kit(Bioengineering Research Institute is built up in Nanjing).
5.2. the measurement of serum oxidative index
Serum T-AOC:Every 1 mL serum is one total when making the absorbance value of reaction system is every to increase by 0.01 per minute for 37 DEG C
Oxidation resistance unit.
SOD in serum:Xanthine oxidase, corresponding SOD amount is when SOD inhibiting rate is up to 50% in every 1 mL reaction solution
One SOD unit of activity.
The above index is measured using ultraviolet-uisible spectrophotometer, and concrete operations are illustrated to carry out by kit(Nanjing is built up
Bioengineering Research Institute).
6. data processing and result judgement
Variance analysis is generally used, but need to first carry out homogeneity test of variance by the program of variance analysis, variance is neat, F value is calculated,
36F value<F0.05, conclusion:No significant difference between each group mean;F value >=F0.05, P≤0.05, with multiple experimental groups and one
The comparative approach two-by-two of mean is counted between a control group;Variable appropriate is carried out to the data of abnormal or heterogeneity of variance to turn
It changes, after meeting normal state or variance and requiring together, is counted with the data after conversion;If variable conversion after still be not up to normal state or
The neat purpose of variance, uses rank sum test instead and is counted.
Results of animal determines:
Reduce blood fat function result judgement:Model control group and blank control group compare, and serum triglyceride increases, the total gallbladder of serum
Sterol or low density lipoprotein cholesterol increase, and difference has conspicuousness, and decision model is set up.(1)Each dosage group and model pair
Compare according to group, any dosage group serum total cholesterol or low density lipoprotein cholesterol reduce, and any dosage group serum glycerol
Three esters reduce, and difference has conspicuousness, while each dosage group serum High Density Lipoprotein Cholesterol is not significantly lower than model comparison
Group can determine that the given the test agent blood-fat-decreasing function results of animal is positive.(2)Each dosage group and model control group ratio
Compared with any dosage group serum total cholesterol or low density lipoprotein cholesterol reduce, and difference has conspicuousness, while each dosage group
Serum triglyceride is not significantly higher than model control group, and each dosage group serum High Density Lipoprotein Cholesterol is not significantly lower than model
It is positive to can determine that given the test agent auxiliary reduces cholesterol function results of animal for control group.(3)Each dosage group and model pair
Compare according to group, any dosage group serum triglyceride reduces, and difference has a conspicuousness, while each dosage group serum total cholesterol and
Low density lipoprotein cholesterol is not significantly higher than model control group, and serum High Density Lipoprotein Cholesterol is not significantly lower than model pair
According to group, it is positive to can determine that given the test agent auxiliary reduces triglycerides function results of animal.
Through testing, the results show that Effects of Xuezhikang can be substantially reduced hyperlipidemic mice serum TC and LDL-C is horizontal, inhibiting rate
Respectively 59.1% and 39.6%, meanwhile, it is capable to improve T-AOC and SOD level, improve blood lipid mouse oxidative stress status.This hair
Bright 1 product of embodiment can be effectively improved the plasma lipid profile and oxidative stress status of blood lipid mouse, the most aobvious with effect when high dose
It writes, TC and LDL-C content in serum is enabled to reduce by 54.3% and 36.8% respectively;Mention T-AOC and SOD level respectively simultaneously
High 84.5% and 14.1%, and can reach and normally organize comparable level.
Claims (8)
1. a kind of preparation method of fruit functional red yeast rice, which is characterized in that the fruit functional red yeast rice is to practice No. ten Flight Mutagenesis
Functional mutant red yeast rice strain K10406 is made for raw material, and microbial preservation number is:CGMCC NO.13773.
2. the preparation method of fruit functional red yeast rice as described in claim 1, which is characterized in that
(1)Fresh fruit is taken, it is spare;
(2)Functional red yeast rice strain K10406 is inoculated in using fresh fruit as in the material of primary raw material, fermentation obtains fruit function
Red yeast rice.
3. the preparation method of fruit functional red yeast rice as described in claim 1, which is characterized in that cleaning fresh fruit removes fruit
Core will impregnate together with soybean after fruit slice, mashing, ingredient, and sterilizing is inoculated with functional red yeast rice strain, and fermented and cultured obtains fruit
Functional red yeast rice.
4. the preparation method of fruit functional red yeast rice as described in claim 1, which is characterized in that the fruit is apple.
5. the preparation method of fruit functional red yeast rice as described in claim 1, includes the steps that following:
S1:Pretreatment:Deseeding after fruit cleaning, slice, soybean warm water impregnate 2-12h, mashing;
S2:Ingredient:Each raw material is taken by following parts by weight:Fruit 50-90, soybean 1- after taking cleaning and deseeding in S1 or being enucleated
10, fructose 0.01-0.1, inulin 1-10, wheat germ powder 0.01-0.15 adjust pH 3-4;
S3:Material in sterilizing S2;
S4:Liquid functional red yeast rice strain K10406 is accessed, fermented and cultured obtains fruit functional red yeast rice fermentation liquid, fermentation liquid is dried,
Color value is detected, crushes, obtains fruit functional red yeast rice.
6. the preparation method of fruit functional red yeast rice as described in claim 1, includes the steps that following:
S1:Pretreatment:Deseeding after apple cleaning, slice, soybean warm water impregnate 2-12h, mashing;
S2:Ingredient:Each raw material is taken by following parts by weight:Take the apple 50-90 after cleaning simultaneously deseeding in S1, soybean 1-10, fruit
Sugared 0.01-0.1, inulin 1-10, wheat germ powder 0.01-0.15 adjust pH 3-4;
S3:Material in sterilizing S2;
S4:Liquid functional red yeast rice strain K10406 is accessed, fermented and cultured obtains fruit functional red yeast rice fermentation liquid, fermentation liquid is dried,
Color value is detected, crushes, obtains fruit functional red yeast rice.
7. the preparation method of fruit functional red yeast rice as described in claim 1, includes the steps that following:
S1:Apple and soybean pretreatment:Fresh apple is cleaned, deseeding is sliced, and warm water soaking soybean 2-12h utilizes beater
Obtain the mixed serum of the two;
S2:Ingredient:Each raw material is taken by following parts by weight:Apple 50-90 obtained in S1, soybean 1-10, fructose 0.01-0.1,
Inulin 1-10, wheat germ powder 0.01-0.15 utilize lactic acid tune pH 3-4;
S3:Material in sterilizing S2;
S4:Liquid functional red yeast rice strain is accessed, is planted age 48 hours, inoculum concentration 5-20% fermented and cultured 5-15 days, obtains fruit function
Monas cuspurpureus Went fermentation liquid dries fermentation liquid, carries out color value detection, pulverizes to 600-1000 mesh, sterilizing obtains fruit functional red yeast rice
Powder.
8. the preparation method of fruit functional red yeast rice as described in claim 1, which is characterized in that in S3, sterilization steps be
1kg/cm2, sterilize 20 minutes at 121 DEG C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810724359.1A CN108850923A (en) | 2018-07-04 | 2018-07-04 | A kind of preparation method of fruit functional red yeast rice |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810724359.1A CN108850923A (en) | 2018-07-04 | 2018-07-04 | A kind of preparation method of fruit functional red yeast rice |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108850923A true CN108850923A (en) | 2018-11-23 |
Family
ID=64298655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810724359.1A Pending CN108850923A (en) | 2018-07-04 | 2018-07-04 | A kind of preparation method of fruit functional red yeast rice |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108850923A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110973423A (en) * | 2019-10-17 | 2020-04-10 | 山东本草生物科技有限公司 | Red yeast noni beverage and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102586119A (en) * | 2012-01-03 | 2012-07-18 | 西藏月王生物技术有限公司 | Functional monascus strain, and preparation method and application of functional highland barley monascus prepared by using functional monascus strain |
CN104195051A (en) * | 2014-08-04 | 2014-12-10 | 东莞市天益生物工程有限公司 | Preparation method and product of functional red pitaya yeast |
CN106520451A (en) * | 2016-12-26 | 2017-03-22 | 天津科技大学 | Monascus fruit wine and preparation method thereof |
CN107333940A (en) * | 2017-05-24 | 2017-11-10 | 山东中惠生物科技股份有限公司 | Burdock functional red yeast rice health protection tea and preparation method thereof |
-
2018
- 2018-07-04 CN CN201810724359.1A patent/CN108850923A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102586119A (en) * | 2012-01-03 | 2012-07-18 | 西藏月王生物技术有限公司 | Functional monascus strain, and preparation method and application of functional highland barley monascus prepared by using functional monascus strain |
CN104195051A (en) * | 2014-08-04 | 2014-12-10 | 东莞市天益生物工程有限公司 | Preparation method and product of functional red pitaya yeast |
CN106520451A (en) * | 2016-12-26 | 2017-03-22 | 天津科技大学 | Monascus fruit wine and preparation method thereof |
CN107333940A (en) * | 2017-05-24 | 2017-11-10 | 山东中惠生物科技股份有限公司 | Burdock functional red yeast rice health protection tea and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110973423A (en) * | 2019-10-17 | 2020-04-10 | 山东本草生物科技有限公司 | Red yeast noni beverage and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mekkara nikarthil Sudhakaran et al. | A review on nutritional composition, antinutritional components and health benefits of green gram (Vigna radiata (L.) Wilczek) | |
CN102813120B (en) | Anti-cancer sea cucumber sugar-reducing flour and preparation method thereof | |
CN106798252A (en) | A kind of natto prescription with coordinating intestines and stomach reducing blood lipid thrombus dissolving effect | |
CN110973423A (en) | Red yeast noni beverage and preparation method thereof | |
CN110013027A (en) | A kind of fermentation method for producing of brown rice enzyme powder | |
CN108294231A (en) | It is suitble to the nutritional staple food of patients with diabetes mellitus | |
KR101664380B1 (en) | Method for Making Fermented Food Containing Red Ginseng by Using Mixed Aspergillus Oryzae and Lactic Acid Bacteria | |
Liu et al. | Bioaccessibility and application of soybean isoflavones: a review | |
KR101253658B1 (en) | Manufacturing method of treated puffing and fermentation red ginseng concentrate | |
CN109170863A (en) | A kind of functional sugar ferment and preparation method thereof | |
CN108850923A (en) | A kind of preparation method of fruit functional red yeast rice | |
Haghighi et al. | Designing an all‐apple‐pomace‐based functional dessert formulation | |
CA2267340A1 (en) | Methods and compositions employing red yeast fermentation products | |
CN108887669A (en) | A kind of fruits and vegetables combination ferment and preparation method thereof | |
CN108272088A (en) | Special diet for labour packet | |
CN111528459A (en) | Heat-clearing and lipid-lowering nutritional food taking peony oil as base material and preparation method thereof | |
JP2013177330A (en) | Anti-inflammatory agent including lees of sweet potato distilled spirit or its treated material | |
Ayyadurai et al. | Beneficial role of fermented rice in healthy lifestyle | |
CN108936577A (en) | A kind of compound group preparation method of the edible natural with cardiovascular protective effect | |
KR100533942B1 (en) | Manufacturing method of functional health yogurt containing red yeast rice and/or its extract | |
CN108094858A (en) | It is suitble to the nutritional staple food of patients with diabetes mellitus | |
KR102619375B1 (en) | A composition for improving, preventing and treating of obesity comprising Centella asiatica fermentation extract | |
KR102158337B1 (en) | Composition for preventing, ameliorating or treating fatty liver disease comprising vinegar of Kalopanax septemlobus as effective component | |
CN116058499B (en) | Mediterranean diet fruit and vegetable fat-reducing meal replacement powder and preparation method and application thereof | |
CN107594536A (en) | A kind of health care buccal tablets containing resistant dextrin and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181123 |
|
RJ01 | Rejection of invention patent application after publication |